National Cancer Institute Thesaurus

Last uploaded: June 2, 2026
Id http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C88323
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C88323
Preferred Name

Burixafor

Definitions
An orally bioavailable inhibitor of CXC chemokine receptor 4 (CXCR4) with receptor binding and hematopoietic stem cell-mobilization activities. Burixafor binds to the chemokine receptor CXCR4, thereby preventing the binding of stromal derived factor-1 (SDF-1 or CXCL12) to the CXCR4 receptor and subsequent receptor activation; this may induce the mobilization of hematopoietic stem and progenitor cells from the bone marrow into blood. CXCR4, a chemokine receptor belonging to the G protein-coupled receptor (GPCR) gene family, plays an important role in chemotaxis and angiogenesis and is upregulated in several tumor cell types; CXCL12/CXCR4 interaction induces retention of hematopoietic cells in the bone marrow.
Synonyms
Phosphonic Acid, p-(2-(4-(6-Amino-2-(((trans-4-(((3-(cyclohexylamino)propyl)amino)methyl)cyclohexyl)methyl)amino)-4-pyrimidinyl)-1-piperazinyl)ethyl)-
BURIXAFOR
Burixafor
TG-0054
Type http://www.w3.org/2002/07/owl#Class
Delete Subject Author Type Created
No notes to display